Narrow your search
Listing 1 - 10 of 41 << page
of 5
>>
Sort by

Dissertation
Etude des effets thérapeutiques de l'administration de gènes suicides et de cytokines dans les carcinomatoses péritonéales
Authors: ---
Year: 2000 Publisher: [s. l. : chez l'auteur],

Loading...
Export citation

Choose an application

Bookmark

Abstract


Periodical
Trait d'union.
Author:
ISSN: 22139508 Year: 1985 Publisher: Paris : Société française de biophysique et de médecine nucléaire

Monokines and other non-lymphocytic cytokines : proceedings of an international workshop
Author:
ISBN: 0845141074 9780845141076 Year: 1988 Volume: 8 Publisher: New York A.R. Liss


Book
T and B lymphocytes : origins, properties and roles in immune response
Authors: --- ---
ISBN: 9021920476 Year: 1974 Publisher: Amsterdam Excerpta medica


Book
Cellular and molecular immunology
Authors: --- --- --- ---
ISBN: 9780323479783 0323479782 9780323523240 0323523242 Year: 2018 Publisher: Philadelphia, PA : Elsevier,

Loading...
Export citation

Choose an application

Bookmark

Abstract

"The top required and recommended immunology text worldwide, Cellular and Molecular Immunology by Drs. Abul K. Abbas, Andrew H.H. Lichtman, and Shiv Pillai, is a clear, well-written, and superbly illustrated introduction to the field. The 9th Edition retains a practical, clinical focus while updating and revising all content to ensure clarity and comprehension, bringing readers fully up to date with new and emerging information in this challenging area"--


Periodical
American journal of immunology.
ISSN: 15583775 Year: 2005 Publisher: New York : Dubai : Science Publications, Science Publications


Book
Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology
Authors: ---
ISBN: 3319469053 3319469061 Year: 2016 Publisher: Cham : Springer International Publishing : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

This book discusses the immunotherapeutic potential of Interleukin 12 in the context of clinical oncology, as well as antitumor effects confirmed in preclinical studies and clinical trials in cancer immunotherapy. Due to its ability to activate both innate (NK cells) and adaptive (cytotoxic T lymphocytes) immunities, Interleukin 12 (IL-12) has been regarded as a promising candidate for tumor immunotherapy. However, despite the encouraging results in animal models, only very modest antitumor effects have been confirmed in early clinical trials. Recently, several clinical studies have been initiated in which IL-12 was applied as an adjuvant in cancer vaccines, in gene therapy including locoregional injections of IL-12 plasmid, and in the form of tumor-targeting immunocytokines (IL-12 fused to monoclonal antibodies).

Listing 1 - 10 of 41 << page
of 5
>>
Sort by